Expression of six drug transporters in vaginal, cervical, and colorectal tissues: Implications for drug disposition in HIV prevention
Melanie R. Nicol(University of Minnesota), Angela D. M. Kashuba(University of North Carolina at Chapel Hill), Yuri Fedoriw(University of North Carolina at Chapel Hill), Deanna L. Kroetz(University of California, San Francisco), Stephanie Mathews(University of North Carolina at Chapel Hill), Heather M. A. Prince(Indiana University School of Medicine), Kristine B. Patterson(University of North Carolina at Chapel Hill), Katie R. Mollan(University of North Carolina at Chapel Hill), Michelle Mathews(University of North Carolina at Chapel Hill), Elizabeth J. Geller(Dartmouth College)
Cited by 55
Related Papers
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
|New England Journal of Medicine|2020|1.4k
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
|Nature|2012|1.2k
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
|Annals of Internal Medicine|2020|548
Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission
|Science Translational Medicine|2011|352